Companion Diagnostics Market Research Reports & Industry Analysis
The companion diagnostics market is one of the fastest growing segments of the IVD and clinical lab services markets. In the United States, over half of all FDA approvals for companion diagnostics have occurred since 2010. The closely associated pharmacodiagnostics IVD market is expected to grow annually by over 20%. The wild success of reference laboratories in the companion diagnostics market even prompted the unprecedented expansion of FDA oversight over laboratory developed tests (LDTs).
Companion diagnostics are increasingly integral to the approval of some new pharmaceuticals, illustrating which individuals are most likely to benefit from the drug. With the approval of CDx-assisted therapies, new high-growth markets are opened for lab tests and IVD products.
Companion diagnostics (CDx) include in vivo or medical imaging procedures and in vitro diagnostic (IVD) lab tests used to determine the efficacy of a particular therapy, most commonly pharmaceutical. Genome research in recent decades has illuminated and detailed the role genetics play in drug metabolism and disease etiology. Drugs can now be paired with IVD and medical imaging tests for prescription decisions and therapeutic monitoring. In vitro companion diagnostics are largely molecular assays, though additional formats include immunohistochemistry (IHC) and immunoassays, and are offered as test kits, analyte specific reagents, and laboratory developed tests (LDTs) or a lab testing service.
The majority of companion diagnostics are pharmacodiagnostic lab tests used to assess an individual’s response to drug therapy. Pharmacodiagnostics represents a major front in a healthcare system-wide push towards personalized medicine. Pharmacodiagnostic tests can be used to determine patient response to clopidogrel anticoagulant drugs, appropriate drug dosage, and the prescription of oncology drugs based on genetic markers.
Stay abreast of fast-paced and promising companion diagnostics markets with MarketResearch.com’s collection of market research studies. We offer a wide selection of studies treating companion diagnostic regulation, regional and disease-specific market development, product and test pipelines, and companion diagnostic product market tracking.
Companion Diagnostics Industry Research & Market Reports
-
Companion Animal Diagnostic Services Market Size, Share & Trends Analysis Report By Testing Category (Clinical Chemistry, Cytopathology), By Type, By Animal Type, By Region, And Segment Forecasts, 2025 - 2030
... Growth & Trends The global companion animal diagnostic services market size is expected to reach USD 13.95 billion by 2030, registering a CAGR of 7.51% from 2025 to 2030, according to a new report by ... Read More
-
In Vitro Diagnostic (IVD) Trends and Market Update: December 2024
... to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health ... Read More
-
Global Companion Diagnostics Market Outlook to 2028
... adoption of personalized medicine, which focuses on delivering tailored treatment options based on genetic, environmental, and lifestyle factors of individual patients. The increasing prevalence of chronic diseases, especially cancer, has further contributed to the expansion ... Read More
-
The World Market for Cancer Diagnostics, 2024-2029
... Information’s The World Market for Cancer Diagnostics, 2024-2029 delivers an authoritative and comprehensive analysis of the global cancer in vitro diagnostics (IVD) market, including industry-defining trends, market sizing, and growth opportunities. This report offers an ... Read More
-
Asia-Pacific Companion Diagnostics Market: Focus on Application, End User, Technology, and Country - Analysis and Forecast, 2023-2033
... and is expected to reach $2,849.7 million by 2033, growing at a CAGR of 14.53% between 2023 and 2033. The Asia-Pacific (APAC) companion diagnostics market is growing as a result of increased approvals for companion ... Read More
-
Global Companion Diagnostics Devices Market Growth 2024-2030
... the Companion Diagnostics Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Companion Diagnostics ... Read More
-
Global Companion Diagnostics (CDx) Development Services Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Companion Diagnostics (CDx) Development Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Europe Companion Diagnostics Market: Focus on Application, End User, Technology, and Country - Analysis and Forecast, 2023-2033
... and is expected to reach $3,562.1 million by 2033, growing at a CAGR of 12.30% between 2023 and 2033. Advances in biomedical imaging, a rise in companion diagnostics product approvals, and the rising prevalence of ... Read More
-
Companion Diagnostic Technologies Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 12.4% during 2025-2034. This report on global companion diagnostic technologies market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Global Companion Diagnostics for Oncology Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Companion Diagnostics for Oncology is forecast to a readjusted size of US$ 8436.7 million by 2030 with a CAGR of 11.2% during review period. The research report highlights ... Read More
-
Multiplex Assays Market Size and Forecasts (2020 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis by Type (Nucleic Acid, Protein, Cell-Based Assays); Application (Clinical Diagnostics, Research and Development, Companion Diagnostics, Drug Discovery); and End-User (Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories)
... and End-User (Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories) Multiplex Assays Market Size Estimation: The global multiplex assays market was valued at approximately USD 9.75 billion in 2020 and is projected ... Read More
-
Precision Medicine Market Report by Product (Consumables, Instruments, Services), Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, and Others), Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others), and Region 2024-2032
... User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others), and Region 2024-2032 The global precision medicine market size reached US$ 75.2 Billion in 2023. Looking forward, IMARC Group expects ... Read More
-
Companion Diagnostics Market
... 2024 to USD 22.37 billion by 2032, exhibiting a CAGR of 11.5% during the forecast period of 2024-2032. The COVID-19 pandemic decreased global need for accomplice diagnostics. In 2020, there has been a drop in ... Read More
-
Companion Diagnostics (CDx) Market - Forecasts from 2024 to 2029
... A companion diagnostic (CDx) device is a medical device that enables the user to receive crucial information regarding the use of corresponding drugs or biological products. The prime reason driving the market growth is the ... Read More
-
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032
... Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032 The global companion diagnostics market size reached US$ 6.7 Billion in 2023. ... Read More
-
Theranostics: Global Markets
... competitive landscape, market trends and market dynamics such as drivers, restraints and opportunities. The report provides historic, current and projected market value. By product type, the market is segmented into theranostics equipment and theranostics agents. ... Read More
-
Precision Medicine Market Global Forecast Report by Product (Consumables, Instruments, Services) Technology (Big Data Analytics, Bioinformatic, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others) Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, Others) End User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, Others) Countries and Company Analysis, 2024-2032
... User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, Others) Countries and Company Analysis, 2024-2032 Trauma Fixation Device Market Analysis The global market for trauma fixation devices was US$ 8.13 billion ... Read More
-
Companion Diagnostics Market Market By Technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, and Others), By Indication (Cancer, Neurological Diseases, Infectious Diseases, and Others), By End-user (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), Regional Outlook– Global Forecast up to 2030
... Contract Research Organizations, and Others), Regional Outlook– Global Forecast up to 2030 Therapeutic drugs are used in conjunction with a medical instrument known as a companion diagnostic to evaluate how well they function and how ... Read More
-
Global Companion Diagnostics Market Report and Forecast 2024-2032
... at a CAGR of 12.00% during the forecast period of 2024-2032, driven by increasing technological advancements in molecular biology and genomics. The market is experiencing robust growth and is expected to reach USD 20.3 billion ... Read More
-
Companion Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 12.54% during the forecast period (2024-2029). The promotion of personalized medicine and targeted therapy as a new treatment option by key players, increasing cases of adverse drug ... Read More
-
Biodesix Inc (BDSX) - Product Pipeline Analysis, 2024 Update
... trial support and testing. It markets its products under the brand names including GeneStrat, VeriStrat, Nodify Lung and IQLung. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for ... Read More
-
Companion Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030
... (Pcr), Others), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Others), By End-User (Hospitals, Diagnostic Labs, Others), by geography, is expected to grow at a noteworthy CAGR till 2030 owing to the increase in the ... Read More
-
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... Companion Diagnostics (CDx) market size was valued at USD 9869.6 million in 2023 and is forecast to a readjusted size of USD 24800 million by 2030 with a CAGR of 14.1% during review period. The ... Read More
-
Global Companion Diagnostics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Companion Diagnostics Market by Technology (Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing), Indication (Cancer, Cardiovascular Diseases, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 7.30 billion in 2024, at a CAGR 10.65% to reach USD 13.49 billion by 2030. Companion diagnostics are specialized tests designed to help healthcare professionals determine whether a particular medical ... Read More
Research Assistance
